Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.871 |
High Similarity |
NPD5761 |
Phase 2 |
0.871 |
High Similarity |
NPD5760 |
Phase 2 |
0.8023 |
Intermediate Similarity |
NPD8434 |
Phase 2 |
0.7818 |
Intermediate Similarity |
NPD5537 |
Clinical (unspecified phase) |
0.7733 |
Intermediate Similarity |
NPD6765 |
Approved |
0.7733 |
Intermediate Similarity |
NPD6764 |
Approved |
0.7557 |
Intermediate Similarity |
NPD6784 |
Approved |
0.7557 |
Intermediate Similarity |
NPD6785 |
Approved |
0.7516 |
Intermediate Similarity |
NPD2343 |
Clinical (unspecified phase) |
0.7484 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7439 |
Intermediate Similarity |
NPD3226 |
Approved |
0.7423 |
Intermediate Similarity |
NPD920 |
Approved |
0.7365 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.7312 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.7301 |
Intermediate Similarity |
NPD642 |
Clinical (unspecified phase) |
0.7301 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7296 |
Intermediate Similarity |
NPD1471 |
Phase 3 |
0.7289 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.7246 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.7235 |
Intermediate Similarity |
NPD3749 |
Approved |
0.7232 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.7195 |
Intermediate Similarity |
NPD2533 |
Approved |
0.7195 |
Intermediate Similarity |
NPD2532 |
Approved |
0.7195 |
Intermediate Similarity |
NPD2534 |
Approved |
0.7188 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.7178 |
Intermediate Similarity |
NPD643 |
Clinical (unspecified phase) |
0.717 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.716 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.7152 |
Intermediate Similarity |
NPD6273 |
Approved |
0.7125 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.7118 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.7102 |
Intermediate Similarity |
NPD7893 |
Clinical (unspecified phase) |
0.7063 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.7055 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7052 |
Intermediate Similarity |
NPD5494 |
Approved |
0.7035 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.703 |
Intermediate Similarity |
NPD6799 |
Approved |
0.7024 |
Intermediate Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.7019 |
Intermediate Similarity |
NPD2796 |
Approved |
0.7011 |
Intermediate Similarity |
NPD1247 |
Approved |
0.7006 |
Intermediate Similarity |
NPD3268 |
Approved |
0.7006 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.7 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.6994 |
Remote Similarity |
NPD919 |
Approved |
0.6994 |
Remote Similarity |
NPD2800 |
Approved |
0.6994 |
Remote Similarity |
NPD1243 |
Approved |
0.6989 |
Remote Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.6988 |
Remote Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.6975 |
Remote Similarity |
NPD2344 |
Approved |
0.6975 |
Remote Similarity |
NPD6002 |
Phase 3 |
0.6975 |
Remote Similarity |
NPD6004 |
Phase 3 |
0.6975 |
Remote Similarity |
NPD6003 |
Clinical (unspecified phase) |
0.6975 |
Remote Similarity |
NPD6005 |
Phase 3 |
0.6975 |
Remote Similarity |
NPD6006 |
Clinical (unspecified phase) |
0.6966 |
Remote Similarity |
NPD5844 |
Phase 1 |
0.6959 |
Remote Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.6933 |
Remote Similarity |
NPD1549 |
Phase 2 |
0.6933 |
Remote Similarity |
NPD970 |
Clinical (unspecified phase) |
0.6928 |
Remote Similarity |
NPD1608 |
Approved |
0.6919 |
Remote Similarity |
NPD5402 |
Approved |
0.6914 |
Remote Similarity |
NPD6100 |
Approved |
0.6914 |
Remote Similarity |
NPD6099 |
Approved |
0.6914 |
Remote Similarity |
NPD2935 |
Discontinued |
0.691 |
Remote Similarity |
NPD3818 |
Discontinued |
0.6884 |
Remote Similarity |
NPD8404 |
Phase 2 |
0.6882 |
Remote Similarity |
NPD4380 |
Phase 2 |
0.6879 |
Remote Similarity |
NPD3882 |
Suspended |
0.6879 |
Remote Similarity |
NPD4965 |
Approved |
0.6879 |
Remote Similarity |
NPD6832 |
Phase 2 |
0.6879 |
Remote Similarity |
NPD4967 |
Phase 2 |
0.6879 |
Remote Similarity |
NPD4966 |
Approved |
0.6875 |
Remote Similarity |
NPD6808 |
Phase 2 |
0.6871 |
Remote Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.6871 |
Remote Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.6868 |
Remote Similarity |
NPD8313 |
Approved |
0.6868 |
Remote Similarity |
NPD8312 |
Approved |
0.6867 |
Remote Similarity |
NPD7236 |
Approved |
0.6854 |
Remote Similarity |
NPD7473 |
Discontinued |
0.6848 |
Remote Similarity |
NPD3750 |
Approved |
0.6848 |
Remote Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.6839 |
Remote Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.6821 |
Remote Similarity |
NPD3817 |
Phase 2 |
0.6818 |
Remote Similarity |
NPD8127 |
Discontinued |
0.6818 |
Remote Similarity |
NPD6959 |
Discontinued |
0.6807 |
Remote Similarity |
NPD2309 |
Approved |
0.6805 |
Remote Similarity |
NPD5403 |
Approved |
0.6802 |
Remote Similarity |
NPD1934 |
Approved |
0.6795 |
Remote Similarity |
NPD3266 |
Approved |
0.6795 |
Remote Similarity |
NPD3267 |
Approved |
0.6793 |
Remote Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.6792 |
Remote Similarity |
NPD1699 |
Clinical (unspecified phase) |
0.6792 |
Remote Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.6791 |
Remote Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.6786 |
Remote Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.6786 |
Remote Similarity |
NPD5401 |
Approved |
0.6782 |
Remote Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.6782 |
Remote Similarity |
NPD7768 |
Phase 2 |
0.678 |
Remote Similarity |
NPD6232 |
Discontinued |
0.677 |
Remote Similarity |
NPD1899 |
Clinical (unspecified phase) |
0.6752 |
Remote Similarity |
NPD6007 |
Clinical (unspecified phase) |
0.6748 |
Remote Similarity |
NPD3748 |
Approved |
0.6748 |
Remote Similarity |
NPD1510 |
Phase 2 |
0.6748 |
Remote Similarity |
NPD4308 |
Phase 3 |
0.6732 |
Remote Similarity |
NPD17 |
Approved |
0.6728 |
Remote Similarity |
NPD1607 |
Approved |
0.6725 |
Remote Similarity |
NPD7458 |
Discontinued |
0.6722 |
Remote Similarity |
NPD3751 |
Discontinued |
0.6722 |
Remote Similarity |
NPD7799 |
Discontinued |
0.671 |
Remote Similarity |
NPD9717 |
Approved |
0.6708 |
Remote Similarity |
NPD1240 |
Approved |
0.6705 |
Remote Similarity |
NPD37 |
Approved |
0.6705 |
Remote Similarity |
NPD6234 |
Discontinued |
0.6688 |
Remote Similarity |
NPD2797 |
Approved |
0.6688 |
Remote Similarity |
NPD1203 |
Approved |
0.6687 |
Remote Similarity |
NPD3764 |
Approved |
0.6685 |
Remote Similarity |
NPD3787 |
Discontinued |
0.6685 |
Remote Similarity |
NPD5711 |
Approved |
0.6685 |
Remote Similarity |
NPD5710 |
Approved |
0.6685 |
Remote Similarity |
NPD7229 |
Phase 3 |
0.6667 |
Remote Similarity |
NPD7239 |
Suspended |
0.6667 |
Remote Similarity |
NPD2801 |
Approved |
0.6667 |
Remote Similarity |
NPD8150 |
Discontinued |
0.6667 |
Remote Similarity |
NPD8285 |
Discontinued |
0.6667 |
Remote Similarity |
NPD447 |
Suspended |
0.6648 |
Remote Similarity |
NPD3926 |
Phase 2 |
0.6647 |
Remote Similarity |
NPD7003 |
Approved |
0.6646 |
Remote Similarity |
NPD2798 |
Approved |
0.6629 |
Remote Similarity |
NPD7199 |
Phase 2 |
0.6623 |
Remote Similarity |
NPD1778 |
Approved |
0.6612 |
Remote Similarity |
NPD5953 |
Discontinued |
0.6611 |
Remote Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.6611 |
Remote Similarity |
NPD6166 |
Phase 2 |
0.6611 |
Remote Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.6605 |
Remote Similarity |
NPD4307 |
Phase 2 |
0.6605 |
Remote Similarity |
NPD4140 |
Approved |
0.6603 |
Remote Similarity |
NPD3972 |
Approved |
0.6593 |
Remote Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.6593 |
Remote Similarity |
NPD7286 |
Phase 2 |
0.6584 |
Remote Similarity |
NPD411 |
Approved |
0.6576 |
Remote Similarity |
NPD7685 |
Pre-registration |
0.6566 |
Remote Similarity |
NPD5762 |
Approved |
0.6566 |
Remote Similarity |
NPD5763 |
Approved |
0.6564 |
Remote Similarity |
NPD6355 |
Discontinued |
0.6558 |
Remote Similarity |
NPD5585 |
Approved |
0.6557 |
Remote Similarity |
NPD7074 |
Phase 3 |
0.6548 |
Remote Similarity |
NPD4109 |
Clinical (unspecified phase) |
0.6548 |
Remote Similarity |
NPD4110 |
Phase 3 |
0.6543 |
Remote Similarity |
NPD8032 |
Phase 2 |
0.6541 |
Remote Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.6541 |
Remote Similarity |
NPD5647 |
Approved |
0.6541 |
Remote Similarity |
NPD4419 |
Clinical (unspecified phase) |
0.6541 |
Remote Similarity |
NPD1019 |
Discontinued |
0.6538 |
Remote Similarity |
NPD1547 |
Clinical (unspecified phase) |
0.6538 |
Remote Similarity |
NPD7177 |
Discontinued |
0.6538 |
Remote Similarity |
NPD7228 |
Approved |
0.6534 |
Remote Similarity |
NPD5616 |
Clinical (unspecified phase) |
0.6529 |
Remote Similarity |
NPD1511 |
Approved |
0.6529 |
Remote Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.6522 |
Remote Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.6512 |
Remote Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.6503 |
Remote Similarity |
NPD7054 |
Approved |
0.6471 |
Remote Similarity |
NPD8407 |
Phase 2 |
0.6467 |
Remote Similarity |
NPD7472 |
Approved |
0.6464 |
Remote Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.6457 |
Remote Similarity |
NPD5889 |
Approved |
0.6457 |
Remote Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.6457 |
Remote Similarity |
NPD5890 |
Approved |
0.6453 |
Remote Similarity |
NPD7314 |
Clinical (unspecified phase) |
0.6453 |
Remote Similarity |
NPD1512 |
Approved |
0.6447 |
Remote Similarity |
NPD7435 |
Discontinued |
0.6432 |
Remote Similarity |
NPD6797 |
Phase 2 |
0.6429 |
Remote Similarity |
NPD2424 |
Discontinued |
0.6429 |
Remote Similarity |
NPD2403 |
Approved |
0.6429 |
Remote Similarity |
NPD4575 |
Clinical (unspecified phase) |
0.6424 |
Remote Similarity |
NPD6651 |
Approved |
0.6421 |
Remote Similarity |
NPD4287 |
Approved |
0.6421 |
Remote Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.642 |
Remote Similarity |
NPD6279 |
Approved |
0.642 |
Remote Similarity |
NPD6280 |
Approved |
0.642 |
Remote Similarity |
NPD5952 |
Clinical (unspecified phase) |
0.642 |
Remote Similarity |
NPD6844 |
Discontinued |
0.6415 |
Remote Similarity |
NPD3225 |
Approved |
0.6415 |
Remote Similarity |
NPD1283 |
Approved |
0.6412 |
Remote Similarity |
NPD3887 |
Approved |
0.641 |
Remote Similarity |
NPD3412 |
Clinical (unspecified phase) |
0.6409 |
Remote Similarity |
NPD7315 |
Approved |
0.6408 |
Remote Similarity |
NPD4111 |
Phase 1 |
0.6404 |
Remote Similarity |
NPD7058 |
Phase 2 |
0.6404 |
Remote Similarity |
NPD7057 |
Phase 3 |
0.6402 |
Remote Similarity |
NPD2979 |
Phase 3 |
0.6402 |
Remote Similarity |
NPD7966 |
Clinical (unspecified phase) |
0.64 |
Remote Similarity |
NPD6585 |
Discontinued |
0.6398 |
Remote Similarity |
NPD7251 |
Discontinued |
0.6398 |
Remote Similarity |
NPD7240 |
Approved |
0.6398 |
Remote Similarity |
NPD8368 |
Discontinued |
0.6387 |
Remote Similarity |
NPD9545 |
Approved |
0.6384 |
Remote Similarity |
NPD1465 |
Phase 2 |
0.638 |
Remote Similarity |
NPD6410 |
Clinical (unspecified phase) |
0.6378 |
Remote Similarity |
NPD6777 |
Approved |
0.6378
|
Remote Similarity |
NPD6779 |
Approved |